Compare NOTV & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | COSM |
|---|---|---|
| Founded | 1974 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 18.8M |
| IPO Year | 1997 | 2013 |
| Metric | NOTV | COSM |
|---|---|---|
| Price | $0.54 | $0.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 534.8K | 523.4K |
| Earning Date | 02-04-2026 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $513,024,000.00 | $59,792,819.00 |
| Revenue This Year | $6.49 | $28.14 |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.54 | ★ 6.69 |
| 52 Week Low | $0.47 | $0.28 |
| 52 Week High | $5.67 | $1.32 |
| Indicator | NOTV | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 33.49 | 48.87 |
| Support Level | $0.52 | $0.48 |
| Resistance Level | $0.60 | $0.52 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 34.16 | 69.95 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.